Ishitobi T - Search Results

1

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.

Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K. Hyogo H, et al. Among authors: ishitobi t. Metabolism. 2008 Dec;57(12):1711-8. doi: 10.1016/j.metabol.2008.07.030. Metabolism. 2008. PMID: 19013295 Clinical Trial.

2

Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.

Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M, Ishitobi T, Chayama K, Tazuma S. Hyogo H, et al. Among authors: ishitobi t. J Gastroenterol Hepatol. 2007 Jul;22(7):1112-9. doi: 10.1111/j.1440-1746.2007.04943.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2007. PMID: 17559366

3

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Kimura Y, Hyogo H, Yamagishi S, Takeuchi M, Ishitobi T, Nabeshima Y, Arihiro K, Chayama K. Kimura Y, et al. Among authors: ishitobi t. J Gastroenterol. 2010 Jul;45(7):750-7. doi: 10.1007/s00535-010-0203-y. Epub 2010 Jan 30. J Gastroenterol. 2010. PMID: 20112031 Clinical Trial.

4

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.

Hyogo H, Yamagishi S, Maeda S, Kimura Y, Ishitobi T, Chayama K. Hyogo H, et al. Among authors: ishitobi t. Dig Liver Dis. 2012 Jun;44(6):492-6. doi: 10.1016/j.dld.2011.12.013. Epub 2012 Jan 20. Dig Liver Dis. 2012. PMID: 22265683

5

Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study.

Nakahara T, Hyogo H, Kimura Y, Ishitobi T, Arihiro K, Aikata H, Takahashi S, Chayama K. Nakahara T, et al. Among authors: ishitobi t. Hepatol Res. 2012 Nov;42(11):1065-72. doi: 10.1111/j.1872-034X.2012.01034.x. Epub 2012 May 14. Hepatol Res. 2012. PMID: 22583925

6

Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.

Hyogo H, Yamagishi S, Maeda S, Kimura Y, Ishitobi T, Chayama K. Hyogo H, et al. Among authors: ishitobi t. Clin Biochem. 2012 Dec;45(18):1554-7. doi: 10.1016/j.clinbiochem.2012.07.106. Epub 2012 Aug 3. Clin Biochem. 2012. PMID: 22884488

7

Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.

Hyogo H, Yamagishi S, Maeda S, Fukami K, Ueda S, Okuda S, Nakahara T, Kimura Y, Ishitobi T, Chayama K. Hyogo H, et al. Among authors: ishitobi t. Clin Exp Med. 2014 Feb;14(1):45-51. doi: 10.1007/s10238-012-0223-4. Epub 2012 Nov 23. Clin Exp Med. 2014. PMID: 23179302

8

Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study.

Ishitobi T, Hyogo H, Tokumo H, Arihiro K, Chayama K. Ishitobi T, et al. Hepatol Res. 2014 Apr;44(4):429-35. doi: 10.1111/hepr.12135. Epub 2013 May 15. Hepatol Res. 2014. PMID: 23607264

9

A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion.

Nishioka T, Hyogo H, Numata Y, Yamaguchi A, Kobuke T, Komichi D, Nonaka M, Inoue M, Nabeshima Y, Ogi M, Iwamoto K, Ishitobi T, Ajima T, Chayama K, Tazuma S. Nishioka T, et al. Among authors: ishitobi t. J Atheroscler Thromb. 2005;12(4):211-7. doi: 10.5551/jat.12.211. J Atheroscler Thromb. 2005. PMID: 16141625 Free article.

10

Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.

Kimura Y, Hyogo H, Ishitobi T, Nabeshima Y, Arihiro K, Chayama K. Kimura Y, et al. Among authors: ishitobi t. J Gastroenterol Hepatol. 2011 Mar;26(3):517-22. doi: 10.1111/j.1440-1746.2010.06567.x. J Gastroenterol Hepatol. 2011. PMID: 21054523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters